Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort-Reference-Cited by-同舟云学术

Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort

Published:2010-02 Issue:2 Volume:57 Page:300-309
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fritsche Hans-Martin,Burger Maximilian,Svatek Robert S.,Jeldres Claudio,Karakiewicz Pierre I.,Novara Giacomo,Skinner Eila,Denzinger Stefan,Fradet Yves,Isbarn Hendrik,Bastian Patrick J.,Volkmer Bjoern G.,Montorsi Francesco,Kassouf Wassim,Tilki Derya,Otto Wolfgang,Capitanio Umberto,Izawa Jonathan I.,Ficarra Vincenzo,Lerner Seth,Sagalowsky Arthur I.,Schoenberg Mark,Kamat Ashish,Dinney Colin P.,Lotan Yair,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology

Reference47 articles.

1. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann Oncol,2007

2. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

3. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder;Babjuk;Eur Urol,2008

4. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007

5. Natural history of superficial bladder cancer. Prognostic features and long-term disease course;Heney;Urol Clin North Am,1992

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926;Journal of Clinical Oncology;2024-09-03

2. Bladder-sparing Therapy for Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection;European Urology;2024-08

3. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

4. Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels;European Urology Oncology;2024-06

5. Neoadjuvant chemotherapy prior to radical cystectomy for non-muscle invasive bladder cancer: national trends and pathologic outcomes;Frontiers in Oncology;2024-05-13